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cell histiocytosis in the mandibular condyle
with preservation of the alveolar boneLangerhans cell histiocytosis (LCH) is a rare disease with
unknown pathogenesis. According to the characteristics of
the illness, LCH can be divided into three clinical forms:
eosinophilic granuloma, Hand-Schu¨ller-Christian disease,
and Letterer-Siwe disease. In 1953, Lichtenstein found the
common lesional histiocyte-like cell X in the histological
section of LCH, and he collectively named these diseases
“histiocytosis X” (X represents its unknown etiological
factor).1 Then, the lesional histiocyte-like cell X was found
to be the Langerhans cell; therefore, the disease was
renamed Langerhans cell histiocytosis.2
Here, we reported a case of stage I LCH in a 2-year-old
girl who underwent chemotherapy in 2010. However, she
was found to have recurrence of LCH in the left mandibular
ascending ramus and condylar region in 2011. Head and
neck computed tomography showed a radiolucent bone
lesion near her left mandibular condylar processw20.7 mm
in diameter. A dental panoramic radiograph also revealed a
solitary punched-out osteolytic bone lesion without a
sclerotic border in the left mandibular ascending ramus and
condylar region (Figures 1A and 1B). Aside from these
findings, there were no specific abnormal manifestations
within the oral cavity of the patient, including the teeth
and gingival regions. A biopsy was performed, and the his-
topathological examination showed a sheet of histiocyte-
like cells with coffee-bean nuclei admixed with numerous
eosinophils and few multinucleated giant cells (Figure 2A).
Immunostain revealed that the histiocyte-like cells were
positive for CD1a (Figure 2B). The patient was subsequently
treated with systemic chemotherapy that finally resulted in
a successful lesional regression (Figures 1C and 1D). Ac-
cording to the most recent bone scan in 2015, the bone
lesion was effectively controlled, and the bone wasPlease cite this article in press as: Su C-H, et al., Systemic chemotherap
with preservation of the alveolar bone, Journal of Dental Sciences (20
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article under the CC BY-NC-ND license (http://creativecommons.org/licenreconstructed very well. The patient still received regular
follow-up examinations as an outpatient in the pediatric
oncology department.
Current treatment modalities of LCH include surgical
curettage, excision, radiation therapy, and chemo-
therapy. For focal bone lesions, surgical curettage or
bone resections remain the treatment of choice.2 For
children with LCH involving the mandible, radiation
cannot be used for therapy due to the potential damage
to the permanent dental follicles. Chemotherapy in
combination with steroids and cytotoxic agents could
reduce LCH recurrence while maintaining drug efficacy.2
Therefore, we administered systemic chemotherapy
alone for our patient.
LCH is a rare disease with unknown pathogenesis. The
major key point to diagnose this disease is the identification
of Langerhans cells in the biopsy tissue section. To date,
anti-CD1a immunostaining is the most commonly used
method to identify Langerhans cells in LCH and several
related oral or skin lesions.3e5 Here, we described a LCH
patient treated with systemic chemotherapy alone to ach-
ieve a complete regression of the LCH lesion. Based on
long-term follow-up examinations, the LCH lesion of this
patient has been effectively controlled, and bone regen-
eration has been observed. Dental practitioners should note
that clinical symptoms/signs of LCH include the presenta-
tion of single or multiple bone lesions in the oral and
maxillofacial regions, especially in the jawbone. The
manifestations of LCH in the oral cavity might mimic the
symptoms/signs of common dental problems, such as
moderate or severe periodontitis. Dental practitioners play
important roles in early diagnosis of pediatric patients with
LCH.y alone for Langerhans cell histiocytosis in the mandibular condyle
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Figure 1 Head and neck computed tomography and dental panoramic radiography showing a radiolucent lesion in the left
ascending ramus and condylar region of a pediatric patient (A and B) before and (C and D) after treatment.
Figure 2 The microphotograph of a (A, original magnification: 200) hematoxylin-and-eosin-stained tissue section showing a
sheet of histiocyte-like cells with coffee-bean nuclei admixed with numerous eosinophils and few multinucleated giant cells and (B,
original magnification: 200) an immunostained tissue section showing that the histiocyte-like cells were positive for CD1a.
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